Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA242199
Max Phase: Preclinical
Molecular Formula: C27H27ClN6O4
Molecular Weight: 535.00
Molecule Type: Small molecule
Associated Items:
ID: ALA242199
Max Phase: Preclinical
Molecular Formula: C27H27ClN6O4
Molecular Weight: 535.00
Molecule Type: Small molecule
Associated Items:
Synonyms (1): AR-709
Synonyms from Alternative Forms(1):
Canonical SMILES: COc1cc(Cc2cnc(N)nc2N)c2cc(Cc3c(C(=O)N(C)C)[nH]c4ccc(Cl)cc34)oc2c1OC
Standard InChI: InChI=1S/C27H27ClN6O4/c1-34(2)26(35)22-19(18-9-15(28)5-6-20(18)32-22)11-16-10-17-13(7-14-12-31-27(30)33-25(14)29)8-21(36-3)24(37-4)23(17)38-16/h5-6,8-10,12,32H,7,11H2,1-4H3,(H4,29,30,31,33)
Standard InChI Key: ASSNCSVJAZEMQG-UHFFFAOYSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 535.00 | Molecular Weight (Monoisotopic): 534.1782 | AlogP: 4.42 | #Rotatable Bonds: 7 |
Polar Surface Area: 145.52 | Molecular Species: NEUTRAL | HBA: 8 | HBD: 3 |
#RO5 Violations: 1 | HBA (Lipinski): 10 | HBD (Lipinski): 5 | #RO5 Violations (Lipinski): 1 |
CX Acidic pKa: | CX Basic pKa: 8.15 | CX LogP: 3.38 | CX LogD: 3.19 |
Aromatic Rings: 5 | Heavy Atoms: 38 | QED Weighted: 0.28 | Np Likeness Score: -0.27 |
1. Bennett BC, Xu H, Simmerman RF, Lee RE, Dealwis CG.. (2007) Crystal structure of the anthrax drug target, Bacillus anthracis dihydrofolate reductase., 50 (18): [PMID:17696333] [10.1021/jm070319v] |
2. Ressner RA, Moore MR, Jorgensen JH.. (2008) Activity of the Diaminopyrimidine AR-709 against recently collected multidrug-resistant isolates of invasive Streptococcus pneumoniae from North America., 52 (3): [PMID:18180346] [10.1128/aac.01387-07] |
3. Smith K, Ednie LM, Appelbaum PC, Hawser S, Lociuro S.. (2008) Antistreptococcal activity of AR-709 compared to that of other agents., 52 (6): [PMID:18362189] [10.1128/aac.01620-07] |
4. Jansen WT, Verel A, Verhoef J, Milatovic D.. (2008) In vitro activity of AR-709 against Streptococcus pneumoniae., 52 (3): [PMID:18180358] [10.1128/aac.01332-07] |
Source(1):